Medtronic Inc. has announced that it has received United States Food and Drug Administration (FDA) approval under a humanitarian device exemption (HDE) for the Medtronic Enterra II System. The system is used to treat chronic intractable nausea and vomiting associated with gastroparesis of diabetic or unknown origin when more conservative treatments fail or cannot be tolerated. Medtronic Enterra Therapy consists of a small medical device called ...
Read More
You have just read an article categorized health
titled Enhanced Therapy to Treat Symptoms of Serious Stomach Disorder.
Written by:
editor -
Saturday, January 24, 2015
There are currently no comments for "Enhanced Therapy to Treat Symptoms of Serious Stomach Disorder"
Post a Comment